Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B

World News: . []

Arrowhead Pharmaceuticals Inc NASDAQ ARWR today LINK  that it has received approval from the New LINK  Medicines and Medical LINK  Safety Authority LINK  and from the local Ethics Committee to LINK  with a firs...

More news and information about Arrowhead Pharmaceuticals, Inc.

Published By:

Business Wire: 12:30 GMT Thursday 15th February 2018

Published: .

Search for other references to "arrowhead" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us